A 38-year-old woman with newly diagnosed hypertension (BP 158/98 mmHg on three separate visits) and no symptoms or signs of end-organ damage is seen in the outpatient clinic. Routine investigations (ECG, chest X-ray, serum creatinine, urinalysis) are normal. She denies secondary causes. What is the most appropriate next step in management?
A. Perform 24-hour ambulatory BP monitoring to confirm diagnosis before any intervention
B. Start immediate antihypertensive drug therapy with an ACE inhibitor
C. Refer to a cardiologist for advanced hemodynamic assessment
D. Initiate a 3-month period of lifestyle modifications (DASH diet, sodium restriction, weight loss, exercise) with repeat BP monitoring before considering drug therapy
Explanation
Diagnosis: Stage 1 Hypertension Without End-Organ Damage
This patient has newly diagnosed hypertension (BP consistently ≥140/90 mmHg) with no evidence of end-organ damage and no secondary causes.
Blood Pressure Classification (ACC/AHA 2017)
Table
Category
Systolic (mmHg)
Diastolic (mmHg)
Action
Normal
<120
<80
Lifestyle
Elevated
120–129
<80
Lifestyle
Stage 1 HTN
130–139
80–89
Lifestyle ± drugs (individualized)
Stage 2 HTN
≥140
≥90
Lifestyle + drugs
HTN Emergency
>180
>120
+ end-organ damage
IV agents, ICU
Key Point
In the absence of end-organ damage, diabetes, or CVD, Stage 1 hypertension is managed with lifestyle modification first for 3–6 months before initiating pharmacotherapy. This approach is supported by major guidelines (ACC/AHA, ESC, Indian guidelines).
Lifestyle Modifications (DASH Approach)
Loading diagram...
High-YieldNEET PG
The DASH diet (Dietary Approaches to Stop Hypertension) can reduce BP by 8–14 mmHg — equivalent to a single antihypertensive drug. Combined lifestyle modifications can reduce BP by 20–30 mmHg.
Clinical Pearl
Lifestyle modification is first-line in newly diagnosed hypertension without end-organ damage. It reduces cardiovascular risk, improves overall health, and may prevent or delay need for medications. Rushing to pharmacotherapy in a low-risk patient increases polypharmacy and cost without proven benefit.
Do NOT confuse this with hypertensive urgency or emergency — those require immediate drug therapy. This patient has stable, asymptomatic Stage 1 HTN and is an ideal candidate for lifestyle-first approach.
Harrison 21e Ch 298; Park 26e Ch 8
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.